Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,464
Total Claims
$674K
Drug Cost
444
Beneficiaries
$1,518
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+15%
Opioid rate vs peers
3.0% vs 2.6% avg
+42%
Cost per patient vs peers
$1,518 vs $1,068 avg
+20%
Brand preference vs peers
10.8% vs 9.0% avg
Opioid Prescribing
3.0%
Opioid Rate
280
Opioid Claims
$2,747
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,013 claims · $514K
Generic: 8,375 claims · $155K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 126 | $97K |
| Rivaroxaban | 73 | $69K |
| Dulaglutide | 53 | $60K |
| Insulin Glargine,hum.Rec.Anlog | 47 | $40K |
| Sitagliptin Phosphate | 44 | $28K |
| Budesonide/Formoterol Fumarate | 38 | $21K |
| Fluticasone/Umeclidin/Vilanter | 29 | $21K |
| Insulin Detemir | 17 | $17K |
| Fluticasone Propion/Salmeterol | 14 | $6,250 |
| Ipratropium/Albuterol Sulfate | 12 | $6,214 |
| Rosuvastatin Calcium | 301 | $5,928 |
| Gabapentin | 319 | $5,517 |
| Levothyroxine Sodium | 395 | $5,034 |
| Estrogen,con/M-Progest Acet | 13 | $4,040 |
| Clonidine | 29 | $3,880 |
Prescribing Profile
Patient Profile
74
Avg Age
53%
Female
1.09
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data